(IBDS) iShares iBonds Dec 2027 - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46435UAA97

Corporate Bonds, Investment Grade, 2027 Maturity, USD

Description: IBDS iShares iBonds Dec 2027 November 09, 2025

The iShares iBonds Dec 2027 Term Corporate ETF (IBDS) is a target-maturity fund that must allocate at least 80 % of its net assets to the securities that make up its underlying index and at least 90 % to fixed-income instruments of the same type. The index tracks U.S.-dollar-denominated, investment-grade corporate bonds that all mature in 2027.

Key metrics as of the latest reporting period show an average effective duration of roughly 4.8 years and a weighted-average credit rating near AA, indicating relatively low default risk. The fund’s yield to maturity is currently around 4.4 %, reflecting the prevailing 10-year Treasury rate plus a modest credit spread. Sector exposure is diversified, with the largest allocations to industrials, consumer discretionary, and technology, which together account for about 45 % of holdings.

For a deeper dive into IBDS’s projected cash-flow profile and sector-level credit risk, the ValueRay platform provides detailed analytics that can help you assess whether the fund aligns with your risk-return objectives.

IBDS ETF Overview

Market Cap in USD 3,404m
Category Target Maturity
TER 0.10%
IPO / Inception 2017-09-12

IBDS ETF Ratings

Growth Rating 63.0%
Fundamental -
Dividend Rating 70.2%
Return 12m vs S&P 500 -7.61%
Analyst Rating -

IBDS Dividends

Dividend Yield 12m 4.36%
Yield on Cost 5y 4.63%
Annual Growth 5y 9.39%
Payout Consistency 95.1%
Payout Ratio %

IBDS Growth Ratios

Growth Correlation 3m 95.7%
Growth Correlation 12m 99.4%
Growth Correlation 5y 27.1%
CAGR 5y 5.75%
CAGR/Max DD 3y (Calmar Ratio) 1.75
CAGR/Mean DD 3y (Pain Ratio) 9.47
Sharpe Ratio 12m -2.33
Alpha -6.23
Beta 0.560
Volatility 1.20%
Current Volume 731.9k
Average Volume 20d 709.5k
Stop Loss 23.5 (-3.2%)
Signal 0.89

What is the price of IBDS shares?

As of November 09, 2025, the stock is trading at USD 24.27 with a total of 731,885 shares traded.
Over the past week, the price has changed by +0.11%, over one month by +0.32%, over three months by +1.26% and over the past year by +5.34%.

Is iShares iBonds Dec 2027 a good stock to buy?

Yes. Based on ValueRay's Analyses, iShares iBonds Dec 2027 (NYSE ARCA:IBDS) is currently (November 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.98 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBDS is around 23.39 USD . This means that IBDS is currently overvalued and has a potential downside of -3.63%.

Is IBDS a buy, sell or hold?

iShares iBonds Dec 2027 has no consensus analysts rating.

What are the forecasts/targets for the IBDS price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 26 7.1%

IBDS Fundamental Data Overview November 04, 2025

Market Cap USD = 3.40b (3.40b USD * 1.0 USD.USD)
Beta = 0.56
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.40b USD (3.40b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 3.40b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.40b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.08% (E(3.40b)/V(3.40b) * Re(8.08%) + (debt-free company))
Discount Rate = 8.08% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for IBDS ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle